| Gene Symbol | TFEB |
| Aliases | Transcription Factor EB |
| Protein Type | Transcription Factor |
| Target Class | Protein |
| Function | TFEB is constitutively expressed in most cell types, with highest expression in tissues with high lysosomal activity including: |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction |
| Primary Expression | most cell types, with highest expression in tissues with high lysosomal activity including: |
| Subcellular Localization | and transcriptional activity. Dysregulation of TFEB contributes to impaired protein clearance and accumulation of toxic |
| Druggability | Undruggable (0.23) |
| Molecular Weight | 53 kDa |
| Pathways | mTOR |
| GeneCards | TFEB |
| Human Protein Atlas | TFEB |
| Associated Diseases | aging, Als, Alzheimer, Alzheimer's disease, Amyotrophic Lateral Sclerosis |
| Known Drugs/Compounds | Ampk Activators, bortezomib, curcumin, CURCUMIN, digoxin, ELTROMBOPAG |
| Interactions | 14-3-3, ABCA1, ACAT1, ACETYL-COA, ACHE, ACOD1 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | GBA1 Loss Triggers a TFEB-to-TFE3 Compensatory Swi Cell-Type Specific TFEB Modulation The Mitochondrial-Lysosomal Metabolic Coupling Dys (+17 more) |
| KG Connections | 3092 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!